For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Glycosyn LLC

USPTO Granted Patents = 20

CIPO Patents = 3

EPO Patents = 5

Forward Citations = 56

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

John M McCoy (20 out of 60 patents)

Massimo Merighi (18 out of 18 patents)

Matthew Ian Heidtman (18 out of 18 patents)

4. David S Newburg (4 out of 17 patents)

5. Ardythe L Morrow (2 out of 15 patents)

6. Zhuoteng Yu (2 out of 2 patents)

7. Srikrishnan Mallipeddi (1 out of 1 patent)

8. John M Mccoy (0 patent)

9. Ian Matthew Heidtman (0 patent)

20 patents: Sort by Forward Citations

1. 11643675 - Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides (2023-05-09),

2. 11618912 - Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides (2023-04-04),

3. 11453900 - Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides (2022-09-27),

4. 11331329 - Fucosylated oligosaccharides for prevention of coronavirus infection (2022-05-17),

5. 11324766 - 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation (2022-05-10),

6. 11274325 - Sialyltransferases and uses thereof (2022-03-15),

7. 11236376 - Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides (2022-02-01),

8. 11046984 - Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides (2021-06-29),

9. 11028419 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2021-06-08),

10. 10815511 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2020-10-27),

11. 10487346 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2019-11-26),

12. 10415069 - Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides (2019-09-17),

13. 10286001 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics (2019-05-14),

14. 10273516 - Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides (2019-04-30),

15. 9970018 - Biosynthesis of human milk oligosaccharides in engineered bacteria (2018-05-15),

Glycosyn LLC is a leading biotechnology company specializing in the research and development of innovative glycosylation-based therapeutics. We are committed to addressing unmet medical needs and improving patient outcomes through the advancement of our proprietary glycosylation platform. Our team of experts combines deep scientific expertise with cutting-edge technologies to develop novel treatments for a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. With a focus on precision and efficacy, Glycosyn is at the forefront of revolutionizing the field of glycoscience and transforming the future of medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

20 Patents

#58 in Waltham, MA

#941 in Massachusetts

#15,887 in US

#30,350 in the World

Waltham, MA, United States of America

Glycosyn LLC

Forward Citations = 56

7 inventors:

John M McCoy (20 out of 60 patents)

Massimo Merighi (18 out of 18 patents)

Matthew Ian Heidtman (18 out of 18 patents)

4. David S Newburg (4 out of 17 patents)

5. Ardythe L Morrow (2 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…